GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Singapore O&G Ltd (SGX:1D8) » Definitions » COGS-to-Revenue

Singapore O&G (SGX:1D8) COGS-to-Revenue : 0.17 (As of Dec. 2021)


View and export this data going back to 2015. Start your Free Trial

What is Singapore O&G COGS-to-Revenue?

Singapore O&G's Cost of Goods Sold for the six months ended in Dec. 2021 was S$3.72 Mil. Its Revenue for the six months ended in Dec. 2021 was S$21.34 Mil.

Singapore O&G's COGS to Revenue for the six months ended in Dec. 2021 was 0.17.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Singapore O&G's Gross Margin % for the six months ended in Dec. 2021 was 82.57%.


Singapore O&G COGS-to-Revenue Historical Data

The historical data trend for Singapore O&G's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Singapore O&G COGS-to-Revenue Chart

Singapore O&G Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
COGS-to-Revenue
Get a 7-Day Free Trial 0.15 0.14 0.16 0.17 0.17

Singapore O&G Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 0.17 0.17 0.17 0.17

Singapore O&G COGS-to-Revenue Calculation

Singapore O&G's COGS to Revenue for the fiscal year that ended in Dec. 2021 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=7.369 / 42.397
=0.17

Singapore O&G's COGS to Revenue for the quarter that ended in Dec. 2021 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=3.72 / 21.34
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Singapore O&G  (SGX:1D8) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Singapore O&G's Gross Margin % for the six months ended in Dec. 2021 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 3.72 / 21.34
=82.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Singapore O&G COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Singapore O&G's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Singapore O&G (SGX:1D8) Business Description

Traded in Other Exchanges
N/A
Address
229 Mountbatten Road, No. 02-02 Mountbatten Square, Singapore, SGP, 398007
Singapore O&G Ltd is a Singapore based group of medical practioners dedicated to women's health and wellness in the obstetrics and gynaecology field. Its areas of specialisation are pregnancy care and delivery; the female reproductive system; gynaecological and breast cancer; skin and aesthetic treatments; and other ancillary medical services. The segments of the group are Obstetrics and Gynaecology, Cancer-related, Dermatology, Paediatrics and Corporate. It generates a majority of the revenue from the Obstetrics and Gynaecology Segment which relates to general obstetrics, labour and delivery, general gynaecology and surgery, female pelvic medicine, and urogynaecology and reconstructive surgery. All the operations of the organization are carried out in Singapore.

Singapore O&G (SGX:1D8) Headlines

No Headlines